Basic Information
ID DDInter1082
Drug Type biotech
Protein Chemical Formula None
Protein Average Weight -
CAS Number 320367-13-3
Description Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type 2 diabetes mellitus (T2DM). It is sold under the brand name Adlyxin by Sanofi-Aventis. Adlyxin recieved FDA approval July 28, 2016 [L763].
ATC Classification A10AE54 A10BJ03
Sequences > Lixisenatide Sequence HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPSKKKKKK
Useful Links DrugBank ChEBI PubChem Substance KEGG Drug ChemSpider Wikipedia ChEMBL
Interactions with Lixisenatide
Filter:
Severity level ID Name Mechanism Detail
Interactions with diseases
Filter:
Severity level Disease name Text References
Interactions with foods
Filter:
Severity level Food name Description Management Mechanism References
Interactions with compound preparation
Multi-DRUG trade Multi-DRUG Drug type Warning Note